Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Pacira Biosciences, Inc. (PCRX)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Pacira Biosciences, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1396814.
Total stock buying since 2015: $1,511,746.
Total stock sales since 2015: $134,046,095.
Total stock option exercises since 2015: $25,248,807.
Table 3. Detailed insider trading at Pacira Biosciences, Inc. (PCRX)
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2025-06-04 | Riker Lauren (Senior Vice President, Finance) | Sale | 5,578 | 26.21 | 146,199 |
2025-06-04 | Williams Kristen (Chief Administrative Officer) | Sale | 14,376 | 26.24 | 377,226 |
2025-01-06 | Slonin Jonathan (Chief Medical Officer) | Sale | 879 | 18.40 | 16,173 |
2024-12-13 | Gaugler Daryl (Chief Operating Officer) | Sale | 500 | 19.76 | 9,880 |
2024-09-13 | Gaugler Daryl (Chief Operating Officer) | Sale | 500 | 12.86 | 6,430 |
2024-08-16 | Bigal Marcelo (Director) | Buy | 1,512 | 13.25 | 20,034 |
2024-08-16 | Brege Laura (Director) | Buy | 1,000 | 12.81 | 12,810 |
2024-08-14 | Yang Michael J. (Director) | Buy | 2,000 | 12.90 | 25,800 |
2024-08-12 | Bigal Marcelo (Director) | Buy | 3,400 | 12.01 | 40,834 |
2024-08-12 | Lee Frank D. (Chief Executive Officer) | Buy | 8,264 | 12.10 | 99,994 |
2024-08-12 | Froimson Mark (Director) | Buy | 1,400 | 11.58 | 16,212 |
2024-08-02 | Slonin Jonathan (Chief Medical Officer) | Sale | 945 | 20.05 | 18,947 |
2024-07-02 | Slonin Jonathan (Chief Medical Officer) | Sale | 2,836 | 28.25 | 80,117 |
2024-06-13 | Gaugler Daryl (Chief Operating Officer) | Sale | 1,000 | 28.38 | 28,380 |
2024-06-13 | Hastings Paul J (Director) | Sale | 880 | 28.38 | 24,974 |
2024-06-13 | Williams Kristen (Chief Administrative Officer) | Sale | 7,452 | 28.38 | 211,487 |
2024-06-12 | Riker Lauren (Senior Vice President, Finance) | Sale | 3,970 | 28.72 | 114,018 |
2024-06-11 | Slonin Jonathan (Chief Medical Officer) | Sale | 5,012 | 28.57 | 143,192 |
2024-03-08 | Pace Gary W (Director) | Sale | 90,000 | 30.60 | 2,754,000 |
2024-03-07 | Pace Gary W (Director) | Sale | 28,257 | 30.81 | 870,598 |
2024-03-06 | Pace Gary W (Director) | Sale | 1,066 | 29.67 | 31,628 |
2023-08-02 | Winston Roy (Chief Medical Officer) | Sale | 509 | 34.88 | 17,751 |
2023-07-05 | Riker Lauren Bullaro (Senior Vice President, Finance) | Sale | 643 | 38.91 | 25,019 |
2023-06-14 | Riker Lauren Bullaro (Senior Vice President, Finance) | Sale | 6,366 | 38.33 | 244,027 |
2023-06-14 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 6,467 | 37.03 | 239,473 |
2023-06-07 | Gaugler Daryl (Chief Operating Officer) | Sale | 1,047 | 37.87 | 39,644 |
2023-06-07 | Slonin Jonathan (Chief Clinical Officer) | Sale | 490 | 37.87 | 18,553 |
2023-06-07 | Ellis Ronald J. Jr. (Chief Strategy Officer) | Sale | 1,162 | 37.87 | 43,999 |
2023-06-07 | Reinhardt Max (President, Rest of World) | Sale | 1,099 | 37.87 | 41,613 |
2023-06-07 | Mcloughlin Dennis (Chief Customer Officer) | Sale | 1,057 | 37.87 | 40,023 |
2023-06-07 | Winston Roy (Chief Medical Officer) | Sale | 1,857 | 37.87 | 70,315 |
2023-06-07 | Riker Lauren Bullaro (Senior Vice President, Finance) | Sale | 616 | 37.87 | 23,324 |
2023-06-07 | Reinhart Charles A. Iii (Chief Financial Officer) | Sale | 1,371 | 37.87 | 51,912 |
2023-06-07 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 1,357 | 37.87 | 51,382 |
2023-06-07 | Stack David M (CEO and Chairman) | Sale | 5,326 | 37.87 | 201,668 |
2023-06-06 | Gaugler Daryl (Chief Operating Officer) | Sale | 1,005 | 38.99 | 39,185 |
2023-06-06 | Molloy Anthony (Chief Lgl & Compliance Officer) | Sale | 4,521 | 38.55 | 174,284 |
2023-06-06 | Slonin Jonathan (Chief Clinical Officer) | Sale | 471 | 38.99 | 18,364 |
2023-06-06 | Ellis Ronald J. Jr. (Chief Strategy Officer) | Sale | 1,114 | 38.99 | 43,435 |
2023-06-06 | Reinhardt Max (President, Rest of World) | Sale | 1,054 | 38.99 | 41,096 |
2023-06-06 | Mcloughlin Dennis (Chief Customer Officer) | Sale | 1,014 | 38.99 | 39,536 |
2023-06-06 | Winston Roy (Chief Medical Officer) | Sale | 1,779 | 38.99 | 69,364 |
2023-06-06 | Riker Lauren Bullaro (Senior Vice President, Finance) | Sale | 591 | 38.99 | 23,043 |
2023-06-06 | Reinhart Charles A. Iii (Chief Financial Officer) | Sale | 1,236 | 38.99 | 48,192 |
2023-06-06 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 1,301 | 38.99 | 50,727 |
2023-06-06 | Stack David M (CEO and Chairman) | Sale | 5,058 | 38.99 | 197,216 |
2023-06-05 | Gaugler Daryl (Chief Operating Officer) | Sale | 1,000 | 38.74 | 38,740 |
2023-06-05 | Molloy Anthony (Chief Lgl & Compliance Officer) | Sale | 2,267 | 38.28 | 86,773 |
2023-06-05 | Brege Laura (Director) | Sale | 600 | 38.74 | 23,244 |
2023-06-05 | Hastings Paul J (Director) | Sale | 580 | 38.34 | 22,236 |
2023-05-31 | Gaugler Daryl (Chief Operating Officer) | Sale | 2,500 | 39.08 | 97,700 |
2023-05-31 | Gaugler Daryl (Chief Operating Officer) | Option Ex | 2,500 | 34.00 | 85,000 |
2023-05-15 | Hastings Paul J (Director) | Sale | 7,000 | 41.85 | 292,950 |
2023-05-15 | Hastings Paul J (Director) | Option Ex | 7,000 | 29.90 | 209,300 |
2023-05-11 | Pace Gary W (Director) | Sale | 5,015 | 41.78 | 209,526 |
2023-05-11 | Pace Gary W (Director) | Option Ex | 7,000 | 29.90 | 209,300 |
2023-04-03 | Brege Laura (Director) | Sale | 7,000 | 40.72 | 285,040 |
2023-04-03 | Brege Laura (Director) | Option Ex | 7,000 | 29.90 | 209,300 |
2023-01-05 | Molloy Anthony (Chief Lgl & Compliance Officer) | Sale | 546 | 38.31 | 20,917 |
2023-01-04 | Molloy Anthony (Chief Lgl & Compliance Officer) | Sale | 158 | 39.09 | 6,176 |
2022-10-07 | Reinhardt Max (President, Rest of World) | Sale | 1,380 | 58.00 | 80,040 |
2022-08-03 | Slonin Jonathan (Chief Clinical Officer) | Sale | 308 | 55.70 | 17,155 |
2022-08-03 | Winston Roy (Chief Medical Officer) | Sale | 476 | 55.70 | 26,513 |
2022-07-11 | Hastings Paul J (Director) | Sale | 533 | 56.95 | 30,354 |
2022-07-05 | Slonin Jonathan (Chief Clinical Officer) | Sale | 924 | 57.19 | 52,841 |
2022-06-14 | Laranjeira Charles Anthony (Chief Technical Officer) | Option Ex | 6,000 | 38.35 | 230,100 |
2022-06-08 | Laranjeira Charles Anthony (Chief Technical Officer) | Sale | 4,937 | 60.57 | 299,034 |
2022-06-08 | Stack David M (CEO and Chairman) | Sale | 13,828 | 60.67 | 839,013 |
2022-06-07 | Molloy Anthony (Chief Lgl & Compliance Officer) | Sale | 2,570 | 59.89 | 153,917 |
2022-06-07 | Reinhardt Max (President, Rest of World) | Sale | 2,433 | 62.00 | 150,846 |
2022-06-07 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 4,649 | 59.51 | 276,661 |
2022-06-06 | Gaugler Daryl (Chief Operating Officer) | Sale | 1,106 | 61.37 | 67,879 |
2022-06-06 | Molloy Anthony (Chief Lgl & Compliance Officer) | Sale | 2,980 | 61.37 | 182,894 |
2022-06-06 | Slonin Jonathan (Chief Clinical Officer) | Sale | 362 | 61.37 | 22,217 |
2022-06-06 | Reinhardt Max (President, Rest of World) | Sale | 2,817 | 61.37 | 172,890 |
2022-06-06 | Mcloughlin Dennis (Chief Customer Officer) | Sale | 2,140 | 61.37 | 131,340 |
2022-06-06 | Winston Roy (Chief Medical Officer) | Sale | 17,546 | 61.96 | 1,087,185 |
2022-06-06 | Winston Roy (Chief Medical Officer) | Option Ex | 6,250 | 34.38 | 214,843 |
2022-06-06 | Riker Lauren Bullaro (Senior Vice President, Finance) | Sale | 1,150 | 61.37 | 70,580 |
2022-06-06 | Laranjeira Charles Anthony (Chief Technical Officer) | Sale | 2,813 | 61.37 | 172,645 |
2022-06-06 | Reinhart Charles A. Iii (Chief Financial Officer) | Sale | 2,516 | 61.37 | 154,416 |
2022-06-06 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 3,969 | 61.37 | 243,593 |
2022-06-06 | Stack David M (CEO and Chairman) | Sale | 11,965 | 61.37 | 734,339 |
2022-05-23 | Slonin Jonathan (Chief Clinical Officer) | Option Ex | 2,000 | 52.37 | 104,740 |
2022-05-09 | Froimson Mark (Director) | Sale | 1,000 | 59.37 | 59,370 |
2022-04-28 | Stack David M (CEO and Chairman) | Option Ex | 22,500 | 10.81 | 243,225 |
2022-04-21 | Reinhardt Max (President, Rest of World) | Sale | 9,824 | 73.25 | 719,647 |
2022-04-21 | Reinhardt Max (President, Rest of World) | Option Ex | 12,500 | 42.54 | 531,750 |
2022-04-20 | Reinhardt Max (President, Rest of World) | Sale | 9,764 | 73.99 | 722,438 |
2022-04-20 | Reinhardt Max (President, Rest of World) | Option Ex | 12,500 | 42.54 | 531,750 |
2022-04-19 | Reinhardt Max (President, Rest of World) | Sale | 9,321 | 72.25 | 673,442 |
2022-04-19 | Reinhardt Max (President, Rest of World) | Option Ex | 12,500 | 42.54 | 531,750 |
2022-04-18 | Reinhardt Max (President, Rest of World) | Sale | 8,941 | 73.55 | 657,610 |
2022-04-18 | Reinhardt Max (President, Rest of World) | Option Ex | 12,500 | 42.54 | 531,750 |
2022-04-06 | Molloy Anthony (Chief Lgl & Compliance Officer) | Sale | 22,500 | 77.00 | 1,732,500 |
2022-04-06 | Molloy Anthony (Chief Lgl & Compliance Officer) | Option Ex | 22,500 | 39.32 | 884,610 |
2022-03-31 | Stack David M (CEO and Chairman) | Option Ex | 22,500 | 10.81 | 243,225 |
2022-03-21 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 7,253 | 72.67 | 527,075 |
2022-03-21 | Williams Kristen Marie (Chief Administrative Officer) | Option Ex | 7,253 | 43.18 | 313,184 |
2022-03-10 | Riker Lauren Bullaro (Senior Vice President, Finance) | Sale | 9,300 | 71.55 | 665,368 |
2022-03-10 | Riker Lauren Bullaro (Senior Vice President, Finance) | Option Ex | 9,300 | 10.81 | 100,533 |
2022-03-03 | Longenecker John P Phd (Director) | Sale | 7,000 | 71.73 | 502,145 |
2022-03-03 | Longenecker John P Phd (Director) | Option Ex | 7,000 | 10.81 | 75,670 |
2022-03-03 | Pace Gary W (Director) | Option Ex | 7,000 | 10.81 | 75,670 |
2022-03-01 | Pace Gary W (Director) | Sale | 1,359 | 67.75 | 92,072 |
2022-03-01 | Pace Gary W (Director) | Option Ex | 1,359 | 11.02 | 14,976 |
2022-02-28 | Pace Gary W (Director) | Sale | 28,641 | 66.83 | 1,914,078 |
2022-02-28 | Pace Gary W (Director) | Option Ex | 28,641 | 11.02 | 315,623 |
2022-02-25 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 2,050 | 66.03 | 135,371 |
2022-02-25 | Williams Kristen Marie (Chief Administrative Officer) | Option Ex | 2,050 | 38.35 | 78,617 |
2022-02-16 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 10 | 65.00 | 650 |
2022-02-16 | Williams Kristen Marie (Chief Administrative Officer) | Option Ex | 10 | 38.35 | 383 |
2022-02-04 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 1,000 | 65.18 | 65,180 |
2022-02-04 | Williams Kristen Marie (Chief Administrative Officer) | Option Ex | 1,000 | 38.35 | 38,350 |
2022-01-25 | Stack David M (CEO and Chairman) | Option Ex | 13,670 | 10.81 | 147,772 |
2022-01-21 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 200 | 65.41 | 13,082 |
2022-01-21 | Williams Kristen Marie (Chief Administrative Officer) | Option Ex | 200 | 38.35 | 7,670 |
2022-01-19 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 2,199 | 65.51 | 144,056 |
2022-01-19 | Williams Kristen Marie (Chief Administrative Officer) | Option Ex | 2,199 | 38.35 | 84,331 |
2022-01-18 | Molloy Anthony (Chief Lgl & Compliance Officer) | Sale | 224 | 63.55 | 14,235 |
2022-01-18 | Riker Lauren Bullaro (Senior Vice President, Finance) | Sale | 2,500 | 64.97 | 162,430 |
2022-01-18 | Riker Lauren Bullaro (Senior Vice President, Finance) | Option Ex | 2,500 | 10.81 | 27,025 |
2022-01-18 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 23,440 | 65.69 | 1,539,773 |
2022-01-18 | Williams Kristen Marie (Chief Administrative Officer) | Option Ex | 23,440 | 43.44 | 1,018,116 |
2022-01-11 | Stack David M (CEO and Chairman) | Option Ex | 15,000 | 10.81 | 162,150 |
2021-11-22 | Laranjeira Charles Anthony (Chief Technical Officer) | Option Ex | 7,500 | 44.10 | 330,750 |
2021-11-16 | Stack David M (CEO and Chairman) | Option Ex | 15,000 | 10.81 | 162,150 |
2021-11-04 | Winston Roy (Chief Medical Officer) | Option Ex | 10,000 | 48.15 | 481,500 |
2021-07-29 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 90 | 60.81 | 5,472 |
2021-07-29 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 90 | 10.81 | 972 |
2021-07-28 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 2,410 | 60.85 | 146,648 |
2021-07-28 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 2,410 | 10.81 | 26,052 |
2021-07-02 | Reinhardt Max (President, Rest of World) | Sale | 421 | 59.76 | 25,158 |
2021-06-11 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 2,003 | 59.85 | 119,879 |
2021-06-10 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 5,689 | 60.00 | 341,340 |
2021-06-04 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 1,047 | 61.04 | 63,905 |
2021-06-04 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 3,930 | 61.04 | 239,875 |
2021-06-02 | Manning Donald C. (Chief Medical Officer) | Sale | 2,380 | 62.12 | 147,852 |
2021-05-12 | Stack David M (CEO and Chairman) | Sale | 21,250 | 61.75 | 1,312,187 |
2021-05-12 | Stack David M (CEO and Chairman) | Option Ex | 21,250 | 10.81 | 229,712 |
2021-05-11 | Stack David M (CEO and Chairman) | Sale | 21,250 | 60.98 | 1,295,931 |
2021-05-11 | Stack David M (CEO and Chairman) | Option Ex | 21,250 | 10.81 | 229,712 |
2021-04-13 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 21,823 | 67.25 | 1,467,705 |
2021-04-13 | Williams Kristen Marie (Chief Administrative Officer) | Option Ex | 21,823 | 39.61 | 864,409 |
2021-03-31 | Winston Roy (Chief Clinical Officer) | Sale | 22,224 | 71.19 | 1,582,126 |
2021-03-31 | Winston Roy (Chief Clinical Officer) | Option Ex | 13,750 | 34.38 | 472,656 |
2021-03-17 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 2,000 | 70.01 | 140,020 |
2021-03-17 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 2,000 | 10.81 | 21,620 |
2021-03-15 | Froimson Mark (Director) | Sale | 734 | 72.26 | 53,038 |
2021-03-15 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 1,520 | 73.28 | 111,385 |
Insider trading activities including stock purchases, stock sales, and option exercises
of PCRX listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Pacira Biosciences, Inc. (symbol PCRX,
CIK number 1396814) see
the Securities and Exchange Commission (SEC) website.